Mary Robinson and Her Many Masks Essay -- Poet Poem Actress Essays

Mary Robinson and Her Many Masks Mary Robinson’s public image as an actress and at times transgressive female are inseparable from her identity as an author and poet. Having begun her public life as an actress, Robinson remained keenly conscious of the power of audience. She intentionally re-scripted her own past, using her lurid fame to launch her successful writing career. Written at the end of her life, The Haunted Beach represents a culmination of efforts to make a serious impact on the world of poetry. Among other daring moves, Robinson's poem effectively engages with a known poet, in its recognizable similarities to Coleridge's Rime, and makes a social commentary on a murder she witnessed. The poem’s vaguely defined relationship with audience mirrors Robinson’s own multiplicity in voice. Just as The Haunted Beach is told by an unidentified observer, ultimately Robinson’s own identity remains unknowable; at best she is a fusion of her many pseudonyms, stage characters, and ideas pres ented in her written works. Much has been written on Robinson’s complicated relationship with the public, as well as her intriguing rapport with contemporary artists such as Coleridge and Wordsworth. In considering â€Å"The Haunted Beach,† one of the last poems Robinson wrote before her death, one must pay with attention to her complex path to artist and public figure; both the poem’s conception and its reception are affected by her public persona and her artistic and social connections. Robinson crafted multiple identities as actress, author and poet, all of which play into her constantly developing poetic project. Poetry became for Robinson not only a forum for earning income and salvaging her damaged reputation, but also a form of self-expre... ....clayfox.com/ashessparks/reports/miles.html>> Feldman, Paula R, Ed. British Women Poets of the Romantic Era: An Anthology. Baltimore, MD: The John Hopkins University Press, 1997. Griggs, Earl Leslie. â€Å"Coleridge and Mrs. Mary Robinson.† Modern Language Notes, 45 (1930): 90-95. Kramer, Lawrence. â€Å"Gender and Sexuality in the Prelude: The Question of Book Seven.† ELH 54 (Autumn 1987): 619-637. Mellor, Anne K. â€Å"Mary Robinson and the scripts of female sexuality.† In Representations of the Self from the Renaissance to Romanticism. Ed. Coleman, Patrick et al. Cambridge University Press: Cambridge, England, 2000. Ockerbloom, Mary Mark, Ed. A Celebration of Women Writers. Pascoe, Judith. Romantic Theatricality: Gender, Poetry and Spectatorship. Ithaca, NY: Cornell University Press, 1997.

Angiomax Case Study

The healthcare industry is extremely different than any other industry in the business world. This, along with the benefits and pricing issues, make this case, on Angiomax, an interesting one to analyze. In determining pricing, positioning, and target markets, it is important to not only understand the product but also look at competition and the chain of users, or the buyers, decision makers, and users, as all are very different in this case, as opposed to many industries when all three of these roles may be portrayed by the same individual(s). Before pricing can be looked at, it is important to determine who the product should be targeted towards. There were a number of studies done by Biogen (the company that created Angiomax) of angioplasty patients which showed that the obvious target should be very high risk patients (patients who had previously had heart attacks within two weeks) due to the significant improvement those patients experienced upon taking doses of Angioplasty as opposed to Heparin, the standard medication which was much less expensive but not as effective. Angioplasty did not show as much significant improvement over Heparin for those lower risk patients. The pricing structure should be based on Angiomax’s value propositions. For the end user, or those high risk patients, Angiomax gives the benefits of (1) more predictable results than Heparin, (2) much lower risk of death, and (3) less prevalent complications and thus less time in the hospital than Heparin patients. However, clearly, the buyer or the hospitals, have more power than end users in the decision making. The value proposition for the lead users, or buyers, is as follows: (1) more predictable results than those of Heparin, (2) Fewer costs of addition complications that are standard with Heparin, (3) Fewer complications from Angiomax leads to better reputation of doctors and hospital, and (4) fewer complications leads to more open beds which means more patients can be served (and more money made). Based on these value propositions, Angiomax should clearly be priced at a premium. It is difficult to price this drug because of its high R&D costs, long development cycle, short period of patent protection, and low FDA approval rate. Furthermore, in order for Angiomax to be successful it must steal market share from the current drug on the market- Heparin, which is priced at $2 per dose versus Angiomax’s $40 per dose. However, Angiomax must educate the buyers and doctors on the enormous value that will be derived from using Angiomax over its competitor. Some rough numbers can be shown to these doctors or managers to show that the cost of complications for Heparin users if $110,252,800 versus Angiomax users at $40,185,600 resulting in savings of $70,067200, which, upon dividing by the 700 major health centers results in $100,096 savings per year. Based on this and a breakeven analysis, in which you analyze the cost of complications + number of patients in the centers and the cost of Heparin, it can be determine that at the price of $835. 4, hospitals can breakeven. Therefore, the price cap is $835. 0, but I think that Angiomax should be priced much lower, at about $400 in order to much more efficiently gain market share since the patent protection is relatively low. Furthermore, the drug can be charged at a premium due to the lack of price sensitivity from price sharing (due to patients with health insurance not having to pay the full price. ) For the future, MDCO may need to change its business model up. Due to the high R&D costs an d the short patent protection in this industry, as well as the â€Å"blockbuster† drugs, it is important that the organization consistently is innovative in the future. Because Angiomax has fewer than ten years left with its patent protection, MDCO must be developing new drugs based on the same value proposition but for other markets. Using data and information from clinical trials, as was done with Angiomax, MDCO should determine which markets will benefit significantly from lowering complications, and therefore can be charged at a premium. In terms of Angiomax, MDCO should look into low cost production processes for the drug, as well as attempting to foster a more successful version of the drug for other segments, such as low risk patients.

The Effects Of Global Warming On The World - 1025 Words

Jacob Keirns Persuasive Paper Miss Beverly March 22, 2016 Global Warming â€Å"Some men aren t looking for anything logical, like money. They can t be bought, bullied, reasoned or negotiated with. Some men just want to watch the world burn.† -Christopher Nolan The late nineteenth century was a time of immense discovery, particularly in the world of science. First theorized in the 1890s, the idea of global warming has been around for just over 100 years, despite it’s relatively recent gain in traction. However, despite irrefutable evidence displayed over the last 40 years, many still consider the idea a farce. The melting of the icecaps, the decline in air quality, as well as the the rising of the sea-level, temperature, and allergen-count†¦show more content†¦This idea of the carbon dioxide emissions warming up the atmosphere proves that though the earth does indeed run on cycles, it is not the cycles that are causing increased temperatures, but rather excess carbon dioxide in the atmosphere. Global warming has also played an active role in the health problems that affect the population. Global warming naysayers persist that the health issues that come with global warming are non-existent. The burning of fossil fuels, sunli ght, warm air, and pollution from power plants combine to create ground level smog. Warmer temperatures and higher concentrations of carbon dioxide in the atmosphere stimulates some plants to grow faster and produce more potent allergens. Chronic allergy problems rank among the most common illnesses that lower productivity . This in turn creates poor air quality and has an adverse effect on the population with breathing disorders(climatehotmap.org) . The warmer temperatures have created milder winters. This has caused an increase in the insect population. The recent increase in the spread of new and existing diseases can be attributed to the insect population, particularly mosquitoes. The increase in the global temperatures has increased the insect population, creating more carriers of disease. (climatehotmap.org) The increase of diseases and health problems proves